Skip to content
Entourage
Case studyPharma

AVI Implementation: 89 Manual Inspectors to 2 Machines

Sterile fill-finish manufacturer with large-scale GMP production

A sterile fill-finish facility ran 89 manual visual inspectors on a single production line. The question was not whether to automate, but how to validate the transition in a GMP environment without disrupting the inspection track record.

The challenge

The situation

The facility ran 89 trained manual visual inspectors on its fill-finish line, with full FTE cost, qualification overhead and scheduling complexity. The business case for automated visual inspection was clear, but the regulatory path required careful preparation: replacing manual inspection under GxP means demonstrating that the AVI system achieves at least equivalent detection performance through a formal probability-of-detection study, run against the manual reference standard before the line changes, with the system fully validated under GAMP 5 before it can operate as the sole inspection method. Without this sequence, the validation package does not hold up under Annex 1 scrutiny.

Our approach

What we delivered

01

Defect library development: catalogue of defect types, sizes and frequencies across the fill-finish output, structured as the reference standard for the probability-of-detection (PoD) study

02

Methodology validation (PoD study): detection study comparing AVI performance against manual inspection, structured to meet EU GMP Annex 1 requirements for AVI as a replacement for manual inspection

03

GAMP 5 computer validation: full validation lifecycle from URS through IQ/OQ/PQ, data integrity and audit trail under EU GMP Annex 11 and 21 CFR Part 11

04

Recipe development: definition and optimisation of machine recipes across all product types on the line, reducing recipe setup time from 42 to 7 days

The outcome

Results & impact

EUR 4.2M annual savings

Full FTE cost reduction from 89 manual inspectors to 2 machine operators, including training, qualification and scheduling overhead.

ROI under 2 years

Capital investment recovered within less than two years, based on annual operating cost delta between manual and automated inspection.

Recipe time 42 to 7 days

Recipe development and qualification time reduced by 83 percent, accelerating product changeover and new product introduction.

Zero validation deviations at go-live

AVI system released with no open deviations and a complete GAMP 5 validation package, inspection-ready from day one.

In summary

The facility operates two AVI machines in place of 89 manual inspectors, with a validated inspection method that holds up under EU and FDA inspection. Annual savings of EUR 4.2M, ROI recovered in under two years, and recipe time reduced by 83 percent.

Regulations & standards considered

  • EU GMP Annex 1 (Manufacture of Sterile Medicinal Products, Revision 2022, Sections 8.123-8.131)
  • ISPE GAMP 5 (2nd Edition, 2022): A Risk-Based Approach to Compliant GxP Computerised Systems
  • EU GMP Annex 11 (Computerised Systems, EudraLex Vol. 4)
  • FDA 21 CFR Part 211.68 (Automatic, Mechanical, and Electronic Equipment)
Sources
  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products (Revision 2022)
  • ISPE GAMP 5, 2nd Edition (2022)
  • EU GMP Annex 11: Computerised Systems (EudraLex Vol. 4)
  • Entourage, avi-savings.theentourage.de (reference project, anonymised)

Your project

A comparable project?

Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.

Prefer direct? +49 89 4161170-0
info@theentourage.de

  • Reply usually within one working day
  • 4 offices: DE · CH · IT · US
  • 100% life sciences